15630634|t|Apolipoprotein E and familial dysbetalipoproteinemia: clinical, biochemical, and genetic aspects.
15630634|a|In humans, apolipoprotein E (apoE) is a polymorphic protein of which three common isoforms can be distinguished, designated apoE2, apoE3, and apoE4. This genetic variation is associated with different plasma lipoprotein levels, different response to diet and lipid-lowering therapy, and a variable risk for cardiovascular disease and Alzheimer's disease. An example of an apoE-mediated, autosomal recessive, lipid disorder is familial dysbetalipoproteinemia (FD), caused by mutations in the apolipoprotein E gene. Homozygosity for APOE*2 (1 in 170 persons) causes FD or type III hyperlipoproteinemia in less than 20% of the adult APOE*2 homozygotes. Less common, dominant negative mutations may also cause the disorder. The patients may present with typical skin lesions and elevated plasma levels of cholesterol and triglycerides, mainly in very-low-density lipoprotein remnants and intermediate-density lipoproteins. The disorder is associated with peripheral and coronary artery disease. Additional gene and environmental factors are necessary for the expression of this hyperlipoproteinemia. Hyperinsulinemia and defects in genes involved in the hydrolysis of triglycerides are associated with this lipid disorder. Diet and weight reduction are effective but usually not sufficient to normalize the lipid levels. Additional therapy with statins or fibrates is necessary and effective in most patients.
15630634	0	16	Apolipoprotein E	Gene	348
15630634	21	52	familial dysbetalipoproteinemia	Disease	MESH:D006952
15630634	101	107	humans	Species	9606
15630634	109	125	apolipoprotein E	Gene	348
15630634	127	131	apoE	Gene	348
15630634	222	227	apoE2	Gene	348
15630634	229	234	apoE3	Gene	348
15630634	240	245	apoE4	Gene	348
15630634	357	362	lipid	Chemical	MESH:D008055
15630634	405	427	cardiovascular disease	Disease	MESH:D002318
15630634	432	451	Alzheimer's disease	Disease	MESH:D000544
15630634	470	474	apoE	Gene	348
15630634	506	520	lipid disorder	Disease	MESH:D011017
15630634	524	555	familial dysbetalipoproteinemia	Disease	MESH:D006952
15630634	557	559	FD	Disease	MESH:D006952
15630634	589	605	apolipoprotein E	Gene	348
15630634	629	635	APOE*2	Gene	348
15630634	662	664	FD	Disease	MESH:D006952
15630634	668	697	type III hyperlipoproteinemia	Disease	MESH:D006952
15630634	728	734	APOE*2	Gene	348
15630634	822	830	patients	Species	9606
15630634	856	868	skin lesions	Disease	MESH:D012871
15630634	899	910	cholesterol	Chemical	MESH:D002784
15630634	915	928	triglycerides	Chemical	MESH:D014280
15630634	1064	1087	coronary artery disease	Disease	MESH:D003324
15630634	1172	1192	hyperlipoproteinemia	Disease	MESH:D006951
15630634	1194	1210	Hyperinsulinemia	Disease	MESH:D006946
15630634	1262	1275	triglycerides	Chemical	MESH:D014280
15630634	1301	1315	lipid disorder	Disease	MESH:D011017
15630634	1401	1406	lipid	Chemical	MESH:D008055
15630634	1450	1458	fibrates	Chemical	MESH:D058607
15630634	1494	1502	patients	Species	9606
15630634	Negative_Correlation	MESH:D058607	MESH:D003324
15630634	Negative_Correlation	MESH:D058607	MESH:D006951
15630634	Positive_Correlation	MESH:D006952	348
15630634	Association	MESH:D003324	348
15630634	Positive_Correlation	MESH:D014280	MESH:D003324
15630634	Association	MESH:D011017	348
15630634	Association	MESH:D012871	348
15630634	Association	MESH:D002318	348
15630634	Negative_Correlation	MESH:D058607	MESH:D012871
15630634	Positive_Correlation	MESH:D002784	MESH:D003324
15630634	Association	MESH:D006946	348
15630634	Association	MESH:D008055	MESH:D003324
15630634	Association	MESH:D014280	348
15630634	Negative_Correlation	MESH:D058607	MESH:D011017
15630634	Association	MESH:D000544	348

